Shares of Dow Chemical plummet
After Kuwait reverses on a joint venture, stocks of Dow and Rohm & Haas fall more than 20%.
NEW YORK (Reuters) -- Shares of Dow Chemical and Rohm & Haas plunged more than 20% Monday after Kuwait scrapped a joint venture with Dow, potentially upsetting its plans to buy rival Rohm & Haas.
Dow, the largest U.S. chemical company, could be hurt even if it goes ahead with the Rohm & Haas buy, as it would be saddled with a large debt load from the deal, analysts said.
Dow had planned to use the proceeds from the joint venture with Kuwait's state-run Petrochemical Industries Co. to repay a large part of the debt financing for the $15.3 billion Rohm & Haas acquisition. Dow was to receive $9 billion from the Kuwaiti deal.
Analysts said Dow would be under pressure to renegotiate its bid for Rohm & Haas or, if possible, walk away from the deal.
Midland, Mich.-based Dow agreed in July to buy Rohm & Haas for $78 a share to broaden its specialty product offerings. The deal carries a termination fee of $750 million for Dow.
HSBC (HBC) analyst Hassan Ahmed said Dow should be looking for ways to extricate itself from the deal. Without the Kuwaiti joint venture, Dow would have to tap into difficult credit markets to be able to shoulder the transaction, he said.
Dow's transformation plan is built on two legs: the $17.4 billion Kuwaiti joint venture and the Rohm & Haas deal, Ahmed said.
"When one leg of the two-leg story has fallen off, how can they stand on just the Rohm & Haas deal?" he asked.
In the past, Dow has said it could close the Rohm & Haas deal without the funds from the Kuwaiti joint venture.
To walk away from the deal, Dow would likely have to prove that Rohm & Haas' business had suffered a "material adverse event" since the deal was signed.
Dow declined to comment on whether the joint venture's collapse would affect its plan to buy Rohm & Haas.
Rohm & Haas said in a statement on Sunday that the completion of Dow's joint venture was not a condition for the closing of the acquisition. It said it was working to complete the deal early next year.
Dow's Difficulties
Dow and other chemical companies are struggling because of recession in most developed countries and a sharp slowdown in emerging economies. The company earlier this month said it would close 20 facilities, divest several businesses and cut 5,000 jobs to cope with the slump.
Dow (DOW, Fortune 500) is eligible to collect up to $2.5 billion in termination fees from the breakup of the Kuwaiti deal. But Barclay's Capital (BCS) analyst Sergey Vasnetsov said he does not expect the company to recover a meaningful amount from Kuwait because of Dow's need to maintain friendly relations with the country.
Shares of Dow were down $3.45, or 18.2%, to $15.47 in afternoon trade, and Rohm & Haas (ROH, Fortune 500) fell $9.80, or 15.4%, to $53.76, both on the New York Stock Exchange.
Kuwait's decision spurred option traders to buy put options in Dow. Such options perform well if a company's shares drop. In Rohm, option traders were also buying puts, particularly those giving holders the right to sell shares at $45 through January, which coincides with the pre-deal share price back in July.
"Options traders seemed to be focusing on a worsening environment for Dow Chemical since Dow has lost the prospect of any cost-saving benefits from the deal with Rohm after Kuwait scrapped its joint venture with Dow," said Andrew Wilkinson, senior market analyst at Interactive Brokers Group (IBKR) in Greenwich, Conn.
"One aspect of this joint venture with Kuwait would have been production of higher-margin specialty chemicals. While it was bad news for Rohm, it seems that option investors are taking it as worse news for Dow."
Citigroup (C, Fortune 500) and Merrill Lynch (MER, Fortune 500) advised Dow on the Kuwaiti joint venture. Citigroup, Merrill and Morgan Stanley (MS, Fortune 500) advised the company on the Rohm & Haas deal.
Dow's shares fell 19.03% to $15.32 on the New York Stock Exchange. 
